Thrombomodulin modulates dendritic cells via both antagonism of high mobility group protein B1 and an independent mechanism.

BACKGROUND Thrombomodulin treatment modulates the properties of dendritic cells (DCs) converting them from immunogenic to tolerogenic and inducing its own expression on DCs. Thrombomodulin binds to the inflammatory mediator, high mobility group protein B1 (HMGB1), antagonizing signalling through its receptor, receptor for advanced glycation end products (RAGE). METHODS To test if soluble thrombomodulin could antagonize HMGB1 signaling via RAGE on DCs. DCs were prepared from mouse bone marrow cells or human monocytes. In some experiments dendritic cells were sorted into thrombomodulin+ and thrombomodulin- populations. Expression of surface maturation markers was determined by flow cytometry following treatment with thrombomodulin in the presence or absence of HMGB1. RESULTS Thrombomodulin+ dendritic cells secrete less HMGB1 into the medium. HMGB1 reduces the effects of thrombomodulin on expression of DC maturation markers. Treatment with thrombomodulin reduces the expression of maturation markers such as CD80 and CD86 and increases the expression of thrombomodulin on the DC surface. Treatment of DCs with neutralizing anti-HMGB1 antibody acted synergistically with thrombomodulin in increasing thrombomodulin expression on DCs. Treatment with thrombomodulin can still reduce the expression of surface markers on DCs derived from mice that are deficient in RAGE showing that thrombomodulin can affect DCs by an alternative mechanism. CONCLUSIONS The results of this study show that thrombomodulin modulates DCs both by antagonizing the interaction of HMGB1 with RAGE and by an independent mechanism.

[1]  H. Salamon,et al.  Differential Gene Expression in Thrombomodulin (TM; CD141)+ and TM− Dendritic Cell Subsets , 2013, PloS one.

[2]  T. van der Poll,et al.  Asthma and coagulation. , 2012, Blood.

[3]  Hua-Lin Wu,et al.  The role of thrombomodulin lectin-like domain in inflammation , 2012, Journal of Biomedical Science.

[4]  J. Morser.  Thrombomodulin links coagulation to inflammation and immunity. , 2012, Current drug targets.

[5]  Y. Takei,et al.  Inhibition of allergic bronchial asthma by thrombomodulin is mediated by dendritic cells. , 2011, American journal of respiratory and critical care medicine.

[6]  E. Conway.  Thrombomodulin and its role in inflammation , 2011, Seminars in Immunopathology.

[7]  T. Saikawa,et al.  RECOMBINANT THROMBOMODULIN PREVENTS HEATSTROKE BY INHIBITION OF HIGH-MOBILITY GROUP BOX 1 PROTEIN IN SERA OF RATS , 2010, Shock.

[8]  Anna M. Keller,et al.  Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells , 2010, The Journal of experimental medicine.

[9]  E. Gabazza,et al.  What has been learnt from the thrombin‐activatable fibrinolysis inhibitor‐deficient mouse? , 2010, Journal of thrombosis and haemostasis : JTH.

[10]  H. Iwasaka,et al.  IN VIVO AND IN VITRO EFFECTS OF THE ANTICOAGULANT, THROMBOMODULIN, ON THE INFLAMMATORY RESPONSE IN RODENT MODELS , 2010, Shock.

[11]  P. Stumbles,et al.  The role of dendritic cells and regulatory T cells in the regulation of allergic asthma. , 2010, Pharmacology & therapeutics.

[12]  H. Rauvala,et al.  Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. , 2010, Biochimica et biophysica acta.

[13]  A. Higure,et al.  Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia , 2009, Critical care medicine.

[14]  M. Bianchi,et al.  Regulation of dendritic- and T-cell fate by injury-associated endogenous signals. , 2009, Critical reviews in immunology.

[15]  P. Sly,et al.  Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a TH2-skewed immune response. , 2009, The Journal of allergy and clinical immunology.

[16]  Chi‐Huey Wong,et al.  Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. , 2008, Blood.

[17]  S. Yamada,et al.  Proteolytic Cleavage of High Mobility Group Box 1 Protein by Thrombin–Thrombomodulin Complexes , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[18]  J. Chun,et al.  Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation , 2008, Nature.

[19]  Sergio E. Baranzini,et al.  Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets , 2008, Nature.

[20]  C. Doglioni,et al.  Maturing Dendritic Cells Depend on RAGE for In Vivo Homing to Lymph Nodes1 , 2008, The Journal of Immunology.

[21]  R. Steinman,et al.  Dendritic cells: Understanding immunogenicity , 2007, European journal of immunology.

[22]  K. Legge,et al.  Respiratory dendritic cells: mediators of tolerance and immunity , 2007, Immunologic research.

[23]  M. Bianchi,et al.  The secretion of HMGB1 is required for the migration of maturing dendritic cells , 2007, Journal of leukocyte biology.

[24]  Masayoshi Takeuchi,et al.  RAGE Control of Diabetic Nephropathy in a Mouse Model , 2006, Diabetes.

[25]  S. Fukumoto,et al.  Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes , 2006, Diabetes.

[26]  M. Bianchi,et al.  HMGB1: guiding immunity from within. , 2005, Trends in immunology.

[27]  Peter P. Nawroth,et al.  Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products1 , 2005, The Journal of Immunology.

[28]  Hiroshi Yamamoto,et al.  The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. , 2005, The Journal of clinical investigation.

[29]  J. Bates,et al.  Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. , 2004, The Journal of clinical investigation.

[30]  M. Matthay,et al.  Coagulation-dependent mechanisms and asthma. , 2004, The Journal of clinical investigation.

[31]  E. Conway,et al.  Novel functions of thrombomodulin in inflammation , 2004, Critical care medicine.

[32]  E. Abraham,et al.  Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein* , 2004, Journal of Biological Chemistry.

[33]  M. Bianchi,et al.  The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.

[34]  P. Hellings,et al.  The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor κB and Mitogen-activated Protein Kinase Pathways , 2002, The Journal of experimental medicine.

[35]  M. Boffa,et al.  Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis , 1997, Thrombosis and Haemostasis.

[36]  J. Chen,et al.  The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin , 1995, The Journal of Biological Chemistry.

[37]  J. Lin,et al.  Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. , 1992, The Journal of clinical investigation.

[38]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[39]  H. Ishii,et al.  Soluble Thrombomodulin Antigen in Conditioned Medium Is Increased by Damage of Endothelial Cells , 1991, Thrombosis and Haemostasis.

[40]  S. Yamamoto,et al.  A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. , 1989, The Journal of biological chemistry.

[41]  R. Rosenberg,et al.  Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells , 1988, Molecular and cellular biology.